You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

AMLODIPINE BESYLATE AND VALSARTAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Amlodipine Besylate And Valsartan patents expire, and what generic alternatives are available?

Amlodipine Besylate And Valsartan is a drug marketed by Alembic, Aurobindo Pharma, Hetero Labs, Lupin, Mylan, Novel Labs Inc, Strides Pharma, Teva Pharms Usa, and Torrent. and is included in nine NDAs.

The generic ingredient in AMLODIPINE BESYLATE AND VALSARTAN is amlodipine besylate; valsartan. There are fifty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the amlodipine besylate; valsartan profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Amlodipine Besylate And Valsartan

A generic version of AMLODIPINE BESYLATE AND VALSARTAN was approved as amlodipine besylate; valsartan by STRIDES PHARMA on March 28th, 2013.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMLODIPINE BESYLATE AND VALSARTAN?
  • What are the global sales for AMLODIPINE BESYLATE AND VALSARTAN?
  • What is Average Wholesale Price for AMLODIPINE BESYLATE AND VALSARTAN?
Summary for AMLODIPINE BESYLATE AND VALSARTAN
Drug patent expirations by year for AMLODIPINE BESYLATE AND VALSARTAN
Recent Clinical Trials for AMLODIPINE BESYLATE AND VALSARTAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alphacait, LLCPhase 2
Haining Health-Coming Biotech Co., Ltd.Phase 2
HK inno.N CorporationPhase 1

See all AMLODIPINE BESYLATE AND VALSARTAN clinical trials

US Patents and Regulatory Information for AMLODIPINE BESYLATE AND VALSARTAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa AMLODIPINE BESYLATE AND VALSARTAN amlodipine besylate; valsartan TABLET;ORAL 091235-004 Mar 30, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma AMLODIPINE BESYLATE AND VALSARTAN amlodipine besylate; valsartan TABLET;ORAL 090011-004 Mar 28, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Torrent AMLODIPINE BESYLATE AND VALSARTAN amlodipine besylate; valsartan TABLET;ORAL 202377-001 Mar 30, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa AMLODIPINE BESYLATE AND VALSARTAN amlodipine besylate; valsartan TABLET;ORAL 091235-001 Mar 30, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic AMLODIPINE BESYLATE AND VALSARTAN amlodipine besylate; valsartan TABLET;ORAL 202713-001 Apr 3, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.